quinoxalines has been researched along with tacrolimus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, Y; Kondo, K; Takamatsu, H; Umemura, K | 1 |
| Calabrese, B; Halpain, S | 1 |
| Butterton, JR; Caro, L; Fandozzi, CM; Feng, HP; Guo, Z; Iwamoto, M; Panebianco, D; Talaty, J; Wolford, D; Yeh, WW | 1 |
| Asatryan, A; Kort, J; Kosloski, MP; Li, H; Liu, W; Mensa, FJ; Pugatch, D; Zhao, W | 1 |
| Chen, HW; Hsieh, CB; Hsieh, TY; Lin, JC | 1 |
| Kao, JH; Yu, ML | 1 |
| Ahmed, S; Ajaimy, M; Campbell, A; Graham, JA; Jorde, UP; Nnani, DU; Patel, SR; Saeed, O | 1 |
2 trial(s) available for quinoxalines and tacrolimus
| Article | Year |
|---|---|
Pharmacokinetic Interactions Between Elbasvir/Grazoprevir and Immunosuppressant Drugs in Healthy Volunteers.
Topics: Administration, Oral; Adult; Antiviral Agents; Area Under Curve; Benzofurans; Cyclosporine; Drug Combinations; Drug Interactions; Female; Humans; Imidazoles; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisone; Quinoxalines; Tacrolimus; Young Adult | 2018 |
Drug-Drug Interactions of Tacrolimus or Cyclosporine With Glecaprevir and Pibrentasvir in Healthy Subjects.
Topics: Administration, Oral; Adult; Area Under Curve; Benzimidazoles; Cyclosporine; Drug Combinations; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Middle Aged; Pyrrolidines; Quinoxalines; Sulfonamides; Tacrolimus; Young Adult | 2019 |
5 other study(ies) available for quinoxalines and tacrolimus
| Article | Year |
|---|---|
Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion.
Topics: Animals; Brain Edema; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Electrocoagulation; Immunosuppressive Agents; Injections, Intraperitoneal; Injections, Intravenous; Intracranial Embolism and Thrombosis; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Tacrolimus | 1998 |
Differential targeting of dynamin-1 and dynamin-3 to nerve terminals during chronic suppression of neuronal activity.
Topics: Animals; Cells, Cultured; Dynamin I; Dynamin III; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Green Fluorescent Proteins; Hippocampus; Immunosuppressive Agents; Neurons; Presynaptic Terminals; Protein Transport; Quinoxalines; Rats; Rats, Wistar; Sodium Channel Blockers; Synapses; Synaptosomes; Tacrolimus; Tetrodotoxin; Time Factors | 2015 |
Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia.
Topics: Adult; Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Drug Combinations; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Liver Transplantation; Living Donors; Proline; Pyrrolidines; Quinoxalines; Sulfonamides; Tacrolimus; Uremia | 2021 |
Reply to "Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia".
Topics: Adult; Aminoisobutyric Acids; Benzimidazoles; Cyclopropanes; Drug Combinations; Hepacivirus; Humans; Lactams, Macrocyclic; Leucine; Liver Transplantation; Living Donors; Proline; Pyrrolidines; Quinoxalines; Sulfonamides; Tacrolimus; Uremia | 2021 |
Effect of glecaprevir/pibrentasvir on weight-adjusted tacrolimus trough/dose ratios in heart and kidney transplant recipients.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lactams, Macrocyclic; Leucine; Proline; Pyrrolidines; Quinoxalines; Retrospective Studies; Sulfonamides; Tacrolimus; Transplant Recipients | 2021 |